Approximately 16% of patients with aortic stenosis undergoing transcatheter aortic valve replacement (2) and 13% of those hospitalized for heart failure with preserved ejection fraction (HFpEF) also have transthyretin amyloid cardiomyopathy, in this case designated as wATTR-CM to denote deposition of wild-type TTR in the heart (3).